Editors Note: This article was last updated on April 28th, 2021. To learn more about PharPoint’s virtual capabilities and our experienced leadership team, visit our leadership page and get in contact with a representative. We’d love to discuss how PharPoint can support your upcoming traditional, virtual, remote, or hybrid clinical trial!
April 21, 2020
Virtual Trials, COVID-19, and the Future of the Industry
As the FDA continues to develop evolving guidelines, our industry has experienced a sudden, paradigm shift towards hybrid and virtual trials, with telemedicine becoming the “norm” for patient interaction across a variety of therapeutic areas. PharPoint is a strong advocate of this approach as an option to incorporate efficiencies for select indications and is positioned to advise clients as the rest of our industry adapts to this change.
“Even after the COVID-19 pandemic has subsided, clinical trial participants may grow accustomed to virtual or home health visits, and be hesitant to participate in more traditional, often travel-heavy, study processes to which the industry is accustomed,” Julie Robey, former Director of Clinical Operations at PharPoint stated.
“PharPoint has anticipated this shift for some time and is ready to advise sponsors on how to navigate the evolving FDA regulations while effectively moving to remote monitoring, tele-visits, home health visits, ePRO, eCOA, and eSource. These approaches directly speak to PharPoint’s flexibility. We’re able to run virtual trials through our existing procedures while offering a consultative, team-building approach.”
About PharPoint Research, Inc.
PharPoint is an award-winning and client focused contract research organization (CRO) that supports biotech, pharmaceutical, and medical device companies of all sizes. PharPoint offers clinical operations, biostatistics, statistical programming, data management, and strategic clinical trial consulting services. With a 95% client retention rate and 900+ clinical trials supported since 2007, PharPoint is able to support sponsors as they consider implementing virtual, remote, and hybrid studies.
For more information about PharPoint’s capabilities, contact our team. We look forward to supporting you.
RELATED RESOURCES
Exploring Standard CRO Timeline Benchmarks
Preparing to work with a top biometrics contract research organization and wondering how their promised data management, biostatistics, and medical writing timelines match up to the industry average? To help sponsors dig into these details and ensure the timelines they’re receiving are competitive, we’re providing PharPoint’s typical timelines alongside research that calculates industry standard timelines, when available.
Our hope is that this document can help sponsors set realistic expectations, confidently ask the right questions of their vendors, and ultimately, partner with a top biometrics CRO that keeps their study moving: because patients are waiting.
eBook contents include:
PharPoint’s short eBook, Standard Clinical Trial Timelines: A Sponsor’s Guide to Evaluating Biometrics CROs, includes the below information.
- Standard database build timeline
- The bigger picture: Considering site identification and study start-up
- Standard mid-study database change timeline
- Standard database lock time
- Six strategies for a faster database lock
- Evaluating database lock to top line results timeline
- Ensuring a rapid delivery
- Evaluating database lock to delivery of tables, listings, and figures (TLF) timeline
- Standard clinical study report delivery timeline
- About PharPoint Research
Compare Standard Clinical Trial Timelines
For instant access to the eBook, fill out the form below.
RELATED RESOURCES